Lechel et al.
JOCArticle
1.19-1.23 (2 m, 2 H each, 20-H, 30-H), 2.45 (mc, 1 H, 10-H), 4.01 (s,
3 H, OMe), 7.28 (s, 1 H, 5-H) ppm. 13C NMR (CDCl3, 126 MHz):
δ 11.4, 11.8, 62.2, 111.2 (q, 3JCF = 2.8 Hz), 120.6 (q, 1JCF = 274
Hz), 144.1 (q, 2JCF = 36.2 Hz), 148.1, 148.5, 162.1 ppm. 19F NMR
(CDCl3, 470 MHz): δ -68.0 (s, CF3), -80.6, -109.0, -120.6,
-125.6 (4 m, ONf) ppm. IR (film): ν 3095-3005 (dC;H),
2950-2840 (C-H), 1745-1595 (CdC) cm-1. HRMS (ESI-TOF):
calcd for C14H10F12NO4S [MH]þ 516.0134, found 516.0135.
Typical Procedure for Suzuki Coupling Reaction: 2-tert-Butyl-
3-(benzyloxy)-4-phenyl-6-(trifluoromethyl)pyridine (20d). A mix-
ture of 4-pyridyl nonaflate 19a (120 mg, 0.198 mmol), phenyl
boronic acid (35 mg, 0.287 mmol), Pd(OAc)2 (2.2 mg, 0.010
mmol), PPh3 (10 mg, 0.039 mmol), and K2CO3 (27 mg, 0.195
mmol) in DMF (2 mL) was heatedto 70 °C for 2 h under anargon
atmosphere. The mixture was allowed to cool to room tempera-
ture and diluted with water (5 mL) and extracted with diethyl
ether (3 ꢀ 5 mL). The combined organic phase was dried with
Na2SO4 and concentrated to dryness. The residue was purified by
chromatography on silica gel (hexane/ethyl acetate = 40:1) to
give 76 mg (99%) of 20d as a colorless solid. Mp 57 °C. 1H NMR
(CDCl3, 500 MHz): δ 1.48 (s, 9 H, t-Bu), 4.48 (s, 2 H, 10-H),
7.08-7.62 (m, 10 H, Ph), 7.52 (s, 1 H, 5-H) ppm. 13C NMR
(CDCl3, 126 MHz): δ 29.4, 38.6, 74.5, 121.0 (q, 3JCF = 2.9 Hz),
121.8 (q, 1JCF = 274 Hz), 127.7, 128.0, 128.3, 128.5, 128.9, 129.0,
136.2, 136.4, 141.0 (q, 2JCF = 34.4 Hz), 143.2, 153.6, 163.2 ppm.
2 H, Ph) ppm. 13C NMR (CDCl3, 126 MHz): δ 28.9, 39.1, 62.0,
113.1 (q, 3JCF = 2.8 Hz), 120.7 (q, 1JCF = 274 Hz), 127.1, 127.5,
129.1, 130.2, 137.0, 142.1 (q, 2JCF = 35.9 Hz), 149.5, 166.3 ppm.
IR (KBr):
1590-1570 (CdC) cm-1
ν 3070-3050 (dC;H), 2960-2870 (C;H),
. HRMS (ESI-TOF): calcd for
C17H18F3NOS [MH]þ 342.1134, found 342.1147.
Preparation of 2-tert-Butyl-N-phenyl-6-(trifluoromethyl)-
3-[2-(trimethylsilyl)ethoxy]pyridin-4-amine (23). A mixture of
4-pyridyl nonaflate 19b (227 mg, 0.368 mmol), Pd2(dba)3 (6.7
mg, 0.007 mmol), XPhos (14 mg, 0.029 mmol), aniline (0.47 mL,
0.478 mmol), and Et3N (0.13 mL, 1.01 mmol) in toluene (1.4
mL) was heated in an ACE-sealed tube to 140 °C for 10 min
under an argon atmosphere. The mixture was allowed to cool to
room temperature, diluted with brine (3 mL), and extracted with
diethyl ether (3 ꢀ 5 mL). The combined organic phase was dried
with Na2SO4 and concentrated to dryness. The residue
was purified by chromatography on silica gel (hexane/ethyl
acetate = 10:1) to give 124 mg (82%) of 23 as a colorless oil.
1H NMR (CDCl3, 700 MHz): δ 0.05 (s, 9 H, TMS), 1.26 (mc, 2
H, 20-H), 1.45 (s, 9 H, t-Bu), 4.00 (mc, 2 H, 10-H), 6.34 (sbr, 1 H,
NH), 7.28 (s, 1 H, 5-H), 7.15-7.19, 7.39-7.42 (2 m, 3 H, 2 H, Ph)
ppm. 13C NMR (CDCl3, 176 MHz): δ -1.4, 19.1, 29.8, 38.2,
70.5, 103.6 (q, 3JCF = 2.5 Hz), 121.7 (q, 1JCF = 274 Hz), 121.7,
2
124.4, 129.8, 143.4, 139.5, 142.1 (q, JCF = 33.9 Hz), 145.6,
161.0 ppm. IR (film): ν 3410 (N;H), 3060-2870 (dC;H, C;
H), 1590-1580 (CdC) cm-1. HRMS (ESI-TOF): calcd for
C21H29F3N2OSi [MH]þ 411.2074, found 411.2092.
IR (KBr):
ν 3090-3040 (dC;H), 3000-2875 (C;H),
1600-1550 (CdC) cm-1. MS (EI): m/z (%) 385 (11) [M]þ, 91
(100). C23H22F3NO (385.4) calcd for C 71.67, H 5.75, N 3.63,
found C 71.73, H 5.59, N 3.68.
Preparation of 2,20-Di-tert-butyl-3,30-dimethoxy-6,60-bis-
(trifluoromethyl)-4,40-bipyridine (24). A mixture of 4-pyridyl
nonaflate 19c (245 mg, 0.461 mmol), PdCl2(dppf) (30 mg,
0.026 mmol), B2Pin2 (59 mg, 0.232 mmol), and K2CO3 (191
mg, 1.38 mmol) in dioxane (3 mL) was heated to 80 °C for 1 d
under an argon atmosphere. The mixture was allowed to cool to
room temperature, diluted with brine (4 mL), and extracted with
dichloromethane (3 ꢀ 5 mL). The combined organic phase was
dried with Na2SO4 and concentrated to dryness. The residue was
purified by chromatography on silica gel (hexane/ethyl
acetate = 40:1) to give 100 mg (93%) of 24 as a colorless solid.
Mp 118-120 °C. 1H NMR (CDCl3, 500 MHz): δ 1.46 (s, 18 H,
t-Bu), 3.41 (s, 6 H, OMe), 7.59 (s, 2 H, 5-H) ppm. 13C NMR
(CDCl3, 176 MHz): δ 29.1, 38.8, 60.6, 120.6 (q, 3JCF = 2.9 Hz),
122.6 (q, 1JCF = 274 Hz), 136.7, 140.9 (q, 2JCF = 35.1 Hz), 154.8,
163.7 ppm. IR (KBr): ν 3005-2850 (dC;H, C;H), 1595-1540
(CdC) cm-1. MS (EI): m/z (%) 464 (14) [M]þ, 449 (60), 433 (100),
403 (20), 69 (10), 57 (92). HRMS (EI): calcd for C22H26F6N2O2
[M]þ 464.18985, found 464.18876. C22H26F6N2O2 (464.4) calcd
for C 56.89, H 5.64, N 6.03, found C 56.45, H 5.14, N 5.89.
Preparation of 2-tert-Butyl-3-methoxy-6-(trifluoromethyl)-
4-(trifluorovinyl)pyridine (21). A mixture of 4-pyridyl nonaflate
19c (261 mg, 0.491 mmol), Pd(OAc)2 (5.5 mg, 0.025 mmol), PPh3
(26 mg, 0.098 mmol), and tributyl(1,2,2-trifluorovinyl)stannane
(292 mg, 0.786 mmol) in DMF (2.3 mL) was heated to 50 °C for 1
d under an argon atmosphere. The mixture was allowed to cool
to room temperature, diluted with brine (3 mL), and extracted
with diethyl ether (3 ꢀ 3 mL). The combined organic phase was
dried with Na2SO4 and concentrated to dryness. The residue
was purified by chromatography on silica gel (hexane/ethyl
acetate = 40:1) to give 112 mg (73%) of 21 as a colorless oil.
1H NMR (CDCl3, 500 MHz): δ 1.42 (s, 9 H, t-Bu), 3.89 (s, 3 H,
OMe), 7.49 (s, 1 H, 5-H) ppm. 13C NMR (CDCl3, 126 MHz):
δ 29.0, 38.7, 60.6 (qd, 5JCF = 3.1 Hz), 119.1, 121.6 (q, 1JCF
=
273 Hz), 124.4 (ddd, JCF = 233, 51.1, 21.9 Hz), 126.6 (ddd,
J
J
CF = 21.9, 5.7, 0.9 Hz), 140.4 (q, 2JCF = 35.3 Hz), 153.2 (ddd,
CF = 294, 283, 51.1 Hz), 155.1, 164.0 ppm. 19F NMR (CDCl3,
470 MHz): δ -67.6 (s, CF3), -96.9 (dd, J = 59.7, 32.2 Hz, 10-F),
-111.0 (dd, J = 115.0, 59.7 Hz, 20-Fb), -170.1 (dd, J = 115.0,
32.2 Hz, 20-Fa) ppm. IR (film): ν 2965-2870 (dC;H, C;H),
1770 (CdC) cm-1. HRMS (ESI-TOF): calcd for C13H13F6NO
[MH]þ 314.0974, found 314.0966.
Acknowledgment. Generous support of this work by the
Alexander von Humboldt foundation (research fellowship
for J. D.), the Deutsche Forschungsgemeinschaft (GRK
1582/1), the Fonds der Chemischen Industrie, and the Bayer
Schering Pharma AG is most gratefully acknowledged. We
Preparation of 2-tert-Butyl-3-methoxy-4-(phenylthio)-6-
(trifluoromethyl)pyridine (22). 4-Pyridyl nonaflate 19c (267 mg,
0.503 mmol), PdCl2(dppf) (41 mg, 0.050 mmol), thiophenol
(62 μL, 0.60 mmol), and K2CO3 (139 mg, 1.01 mmol) were
dissolved in a 4:4:1 mixture of acetone, toluene, and H2O
(4.5 mL) and heated to 70 °C for 1 h under an argon atmosphere
in a microwave reactor. The mixture was allowed to cool to
room temperature, diluted with brine (5 mL), and extracted with
ethyl acetate (3 ꢀ 5 mL). The combined organic phase was dried
with Na2SO4 and concentrated to dryness. The residue was
purified by chromatography on silica gel (hexane/ethyl acetate
= 40:1) to give 156 mg (91%) of 22 as a colorless solid. Mp
52 °C. 1H NMR (CDCl3, 500 MHz): δ 1.45 (s, 9 H, t-Bu), 4.00 (s,
3 H, OMe), 7.47 (s, 1 H, 5-H), 7.23-7.30, 7.48-7.52 (2 m, 3 H,
€
also thank Dr. R. Zimmer (Freie Universitat Berlin) for his
help during preparation of this manuscript.
Supporting Information Available: Characterization data
for all compounds, including copies of 1H and 13C NMR spectra
for all compounds and X-ray crystallographic data for 12 and
37a in CIF format.25,26 This material is available free of charge
(25) Sheldrick, G. M. Acta Crystallogr., Sect. A 1990, 46, 467–473.
(26) Sheldrick, G. M. A program for refining crystal structures, Uni-
€
versitat Gottingen, Germany, 1997.
€
732 J. Org. Chem. Vol. 75, No. 3, 2010